{
  "1": [
    [
      ""
    ]
  ],
  "2": [
    [
      ""
    ]
  ],
  "ipo_details": [
    [
      "IPO Date",
      "February 5, 2025toFebruary 7, 2025"
    ],
    [
      "Listing Date",
      "February 12, 2025"
    ],
    [
      "Face Value",
      "₹10per share"
    ],
    [
      "Issue Price",
      "₹111 per share"
    ],
    [
      "Lot Size",
      "1,200 Shares"
    ],
    [
      "Total Issue Size",
      "54,03,600shares(aggregating up to ₹59.98Cr)"
    ],
    [
      "Fresh Issue",
      "44,03,600shares(aggregating up to ₹48.88Cr)"
    ],
    [
      "Offer for Sale",
      "10,00,000shares of ₹10(aggregating up to ₹11.10Cr)"
    ],
    [
      "Issue Type",
      "BookbuildingIPO"
    ],
    [
      "Listing At",
      "BSE SME"
    ],
    [
      "Share Holding Pre Issue",
      "1,56,00,000shares"
    ],
    [
      "Share Holding Post Issue",
      "2,00,03,600shares"
    ],
    [
      "Market Maker Portion",
      "2,71,200sharesGlobalworth Securities Limited"
    ]
  ],
  "reservation": [
    {
      "Investor Category": "Anchor Investor Shares Offered",
      "Shares Offered": "-"
    },
    {
      "Investor Category": "Market Maker Shares Offered",
      "Shares Offered": "2,71,200 (5.02%)"
    },
    {
      "Investor Category": "QIB Shares Offered",
      "Shares Offered": "10,26,000 (18.99%)"
    },
    {
      "Investor Category": "NII (HNI) Shares Offered",
      "Shares Offered": "20,53,200 (38%)"
    },
    {
      "Investor Category": "Retail Shares Offered",
      "Shares Offered": "20,53,200 (38%)"
    },
    {
      "Investor Category": "Total Shares Offered",
      "Shares Offered": "54,03,600 (100%)"
    }
  ],
  "timeline": [
    [
      "IPO Open Date",
      "Wed, Feb 5, 2025"
    ],
    [
      "IPO Close Date",
      "Fri, Feb 7, 2025"
    ],
    [
      "Tentative Allotment",
      "Mon, Feb 10, 2025"
    ],
    [
      "Initiation of Refunds",
      "Tue, Feb 11, 2025"
    ],
    [
      "Credit of Shares to Demat",
      "Tue, Feb 11, 2025"
    ],
    [
      "Tentative Listing Date",
      "Wed, Feb 12, 2025"
    ],
    [
      "Cut-off time for UPI mandate confirmation",
      "5 PM onFebruary 7, 2025"
    ]
  ],
  "lots": [
    {
      "Application": "Retail (Min)",
      "Lots": "1",
      "Shares": "1200",
      "Amount": "₹1,33,200"
    },
    {
      "Application": "Retail (Max)",
      "Lots": "1",
      "Shares": "1200",
      "Amount": "₹1,33,200"
    },
    {
      "Application": "HNI(Min)",
      "Lots": "2",
      "Shares": "2,400",
      "Amount": "₹2,66,400"
    },
    {
      "Application": "Lot Size Calculator",
      "Lots": "",
      "Shares": "",
      "Amount": ""
    }
  ],
  "promoters_holdings": [
    [
      "Share Holding Pre Issue",
      "97.00%"
    ],
    [
      "Share Holding Post Issue",
      ""
    ]
  ],
  "company_financials": [
    [
      "Period Ended",
      "30 Sep 2024",
      "31 Mar 2024",
      "31 Mar 2023",
      "31 Mar 2022"
    ],
    [
      "Assets",
      "28.89",
      "18.98",
      "12.39",
      "6.59"
    ],
    [
      "Revenue",
      "23.25",
      "44.28",
      "30.28",
      "27.62"
    ],
    [
      "Profit After Tax",
      "6.52",
      "12.54",
      "3.11",
      "2.57"
    ],
    [
      "Net Worth",
      "23.68",
      "17.16",
      "4.6",
      "1.49"
    ],
    [
      "Reserves and Surplus",
      "8.08",
      "17.11",
      "4.57",
      "1.46"
    ],
    [
      "Amount in ₹ Crore"
    ]
  ],
  "KPI": [
    {
      "KPI": "ROE",
      "Values": "73.06%"
    },
    {
      "KPI": "ROCE",
      "Values": "94.16%"
    },
    {
      "KPI": "RoNW",
      "Values": "73.06%"
    },
    {
      "KPI": "PAT Margin",
      "Values": "28.53"
    },
    {
      "KPI": "Price to Book Value",
      "Values": "10.09"
    }
  ],
  "EPS": [
    {
      "": "EPS (Rs)",
      "Pre IPO": "8.04",
      "Post IPO": "6.52"
    },
    {
      "": "P/E (x)",
      "Pre IPO": "13.81",
      "Post IPO": "17.04"
    }
  ],
  "listing_details": [
    [
      "Listing Date",
      "February 12, 2025"
    ],
    [
      "BSE Script Code",
      "544353"
    ],
    [
      "NSE Symbol",
      ""
    ],
    [
      "ISIN",
      "INE0U2L01017"
    ],
    [
      "Final Issue Price",
      "₹111 per share"
    ]
  ],
  "listing_day_trading": [
    {
      "Price Details": "Final Issue Price",
      "BSE SME": "₹111.00"
    },
    {
      "Price Details": "Open",
      "BSE SME": "₹88.85"
    },
    {
      "Price Details": "Low",
      "BSE SME": "₹84.45"
    },
    {
      "Price Details": "High",
      "BSE SME": "₹93.25"
    },
    {
      "Price Details": "Last Trade",
      "BSE SME": "₹93.25"
    }
  ],
  "review": [
    {
      "Review By": "Brokers",
      "Subscribe": "1",
      "Neutral": "0",
      "Avoid": "0"
    },
    {
      "Review By": "Members",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    }
  ],
  "prospectus_links": [
    {
      "title": "Amwill Healthcare IPO DRHP",
      "href": "https://www.bseindia.com/corporates/download/312736/Amwill%20Health%20Care%20Limited%20DRHP_20240527192028.pdf",
      "text": "Amwill Healthcare IPODRHP"
    },
    {
      "title": "Amwill Healthcare IPO Addendum DRHP",
      "href": "https://www.bsesme.com/download/312736/AddendumtotheDRHPAmwill_20241122192810.pdf",
      "text": "Amwill Healthcare IPOAddendum DRHP"
    },
    {
      "title": "Amwill Healthcare IPO RHP",
      "href": "https://www.bseindia.com/downloads/ipo/Amwill%20RHP_040220251653.pdf",
      "text": "Amwill Healthcare IPORHP"
    }
  ],
  "promoters": "The Promoters of the Company are namely Anand Gandhi and Tarun Gandhi.",
  "company_contact_details": {
    "company_name": "Amwill Healthcare Limited",
    "address": "No. 157, 1st Floor,, 2nd Main, r, 2nd Main, 3rd Cross Chamrajpet, Bangalore – 560018, Phone, :, Email, :, Website, :",
    "phone": "+91 8043026281",
    "email": "amwill@amwillhealthcare.com",
    "website": "https://www.amwillhealthcare.com/"
  },
  "ipo_registrar_details": {
    "name": "Bigshare Services Pvt Ltd",
    "phone": "+91-22-6263 8200",
    "email": "investor@bigshareonline.com",
    "website": "https://ipo.bigshareonline.com/IPO_Status.html"
  },
  "about_company": {
    "description": "Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities. The product portfolio of the Company is divided into two categories, namely, The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base. The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo. As of  September 30, 2024, the company has 84 employees on payroll. Competitive Strength",
    "competitive_strengths": [
      "Development of generic dermatological solutions and",
      "Formulating targeted solutions for dermatological issues."
    ]
  },
  "ipo_lead_managers": [
    {
      "name": "Unistone Capital Pvt Ltd",
      "profile_link": "/report/ipo-lead-manager-review/112/176/",
      "title": "About Unistone Capital Pvt Ltd"
    }
  ],
  "listing_gain_percent": "-19.95%"
}